Atorvan Tablet (Atorvastatin Calcium Trihydrate)

Adult dose

The recommended initial dose of atorvastatin is 10 mg once daily, but patients requiring greater reductions in LDL cholesterol levels may start at 20 mg or 40 mg once daily. This medication is administered in a dose range of 10 to 80 mg once daily. Initial and maintenance doses should be individualized based on the treatment goals and patient characteristics, and lipid levels should be analyzed within 2 to 4 weeks after starting treatment and/or adjusting doses.

Child dose

The recommended initial dose for pediatric patients (10 to 17 years) with heterozygous familial hypercholesterolemia is 10 mg once daily, with the recommended maximum dose being 20 mg once daily. Dosing should be adjusted every 4 weeks or longer.

This medication may pose a risk of muscle problems, so any symptoms of muscle pain or weakness should be reported to a doctor immediately. Especially if there is a significant increase in muscle enzyme levels or if myopathy is suspected, the medication should be discontinued. Patients with allergies to this medication or those with severe liver function issues, pregnant or breastfeeding women, and children under the age of 10 should not take this medication. Caution should be exercised when using this medication in patients with liver disease or a history of alcohol abuse, the elderly, and those with decreased renal function. Since this medication can affect liver function, regular liver function tests should be conducted, and the medication should be discontinued immediately if symptoms of hepatitis or jaundice occur. Additionally, this medication may increase the risk of side effects when taken with certain other medications, so any other medications should be disclosed to a doctor or pharmacist. Women of childbearing age should use appropriate contraceptive methods while on this medication and discontinue use if pregnancy is confirmed. Breastfeeding women should not take this medication, and children or the elderly should have their doses adjusted under the guidance of a physician and should be closely monitored for side effects. In cases of overdose, there is no specific antidote, so treatment should be provided according to symptoms, and liver function and muscle enzyme levels should be monitored. The medication should be stored out of reach of children and kept in its original container to prevent degradation and misuse.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reactions, high fever accompanied by severe rashes, blisters, peeling skin, painful mucous membranes of the mouth/eyes, severe skin reactions, shortness of breath or breathing difficulty, asthma attacks, respiratory distress with cough and fever, liver abnormalities (jaundice), yellowing of the skin or eyes, extreme lethargy, sudden and severe headache.

Mild side effects

• Weakness
• fatigue
• chest pain
• peripheral edema
• tiredness
• fever
• nasopharyngitis
• hyperglycemia
• hypoglycemia
• weight gain

This medication should be stored in a tightly sealed container to prevent air or moisture ingress and should be stored at a safe temperature between 1 and 30 degrees Celsius. Proper storage will maintain the medication's effectiveness and prevent degradation.

Appearance

White oval film-coated tablet

Package unit

For domestic use: 30 tablets/bottle, 100 tablets/bottle, for export: 30 tablets (10 tablets/PTP x 3)